Recent Finacing
Recent Raise
Rheostat Therapeutics is a Cambridge-based biotech discovering small molecules that modulate mitophagy and autophagy to restore cellular clearance, advancing programs toward clinical trials and expanding biomarker studies for neurodegeneration.
